BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25900130)

  • 21. New cases and refinement of the critical region in the 1q41q42 microdeletion syndrome.
    Rosenfeld JA; Lacassie Y; El-Khechen D; Escobar LF; Reggin J; Heuer C; Chen E; Jenkins LS; Collins AT; Zinner S; Babcock M; Morrow B; Schultz RA; Torchia BS; Ballif BC; Tsuchiya KD; Shaffer LG
    Eur J Med Genet; 2011; 54(1):42-9. PubMed ID: 20951845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prenatal diagnosis of two cases with 2p15-p16.1 microdeletion syndrome].
    Wan T; Wang J; Shang Y; Liu J; Yu B; Gu J; Yuan P
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Feb; 37(2):186-189. PubMed ID: 32034752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2q33.1q34 Deletion in a Girl with Brain Anomalies and Anorectal Malformation.
    Ronzoni L; Novelli A; Brisighelli G; Peron A; Triulzi F; Bianchi V; Leva E; Bedeschi MF
    Cytogenet Genome Res; 2016; 150(1):23-28. PubMed ID: 27915340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2q31.1 microdeletion syndrome: redefining the associated clinical phenotype.
    Dimitrov B; Balikova I; de Ravel T; Van Esch H; De Smedt M; Baten E; Vermeesch JR; Bradinova I; Simeonov E; Devriendt K; Fryns JP; Debeer P
    J Med Genet; 2011 Feb; 48(2):98-104. PubMed ID: 21068127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of ANKRD11 and ZNF778 as candidate genes for autism and variable cognitive impairment in the novel 16q24.3 microdeletion syndrome.
    Willemsen MH; Fernandez BA; Bacino CA; Gerkes E; de Brouwer AP; Pfundt R; Sikkema-Raddatz B; Scherer SW; Marshall CR; Potocki L; van Bokhoven H; Kleefstra T
    Eur J Hum Genet; 2010 Apr; 18(4):429-35. PubMed ID: 19920853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microdeletion at chromosome 4q21 defines a new emerging syndrome with marked growth restriction, mental retardation and absent or severely delayed speech.
    Bonnet C; Andrieux J; Béri-Dexheimer M; Leheup B; Boute O; Manouvrier S; Delobel B; Copin H; Receveur A; Mathieu M; Thiriez G; Le Caignec C; David A; de Blois MC; Malan V; Philippe A; Cormier-Daire V; Colleaux L; Flori E; Dollfus H; Pelletier V; Thauvin-Robinet C; Masurel-Paulet A; Faivre L; Tardieu M; Bahi-Buisson N; Callier P; Mugneret F; Edery P; Jonveaux P; Sanlaville D
    J Med Genet; 2010 Jun; 47(6):377-84. PubMed ID: 20522426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chromosome 2p15p16.1 microdeletion syndrome: 2.5 Mb deletion in a patient with renal anomalies, intractable seizures and a choledochal cyst.
    Hucthagowder V; Liu TC; Paciorkowski AR; Thio LL; Keller MS; Anderson CD; Herman T; Dehner LP; Grange DK; Kulkarni S
    Eur J Med Genet; 2012; 55(8-9):485-9. PubMed ID: 22579565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2q23.1 microdeletion identified by array comparative genomic hybridisation: an emerging phenotype with Angelman-like features?
    Jaillard S; Dubourg C; Gérard-Blanluet M; Delahaye A; Pasquier L; Dupont C; Henry C; Tabet AC; Lucas J; Aboura A; David V; Benzacken B; Odent S; Pipiras E
    J Med Genet; 2009 Dec; 46(12):847-55. PubMed ID: 18812405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What can we learn from old microdeletion syndromes using array-CGH screening?
    Mosca-Boidron AL; Bouquillon S; Faivre L; Callier P; Andrieux J; Marle N; Bonnet C; Vincent-Delorme C; Berri M; Plessis G; Manouvrier-Hanu S; Dieux-Coeslier A; Thauvin-Robinet C; Pipiras E; Delahaye A; Payet M; Ragon C; Masurel-Paulet A; Questiaux E; Benzacken B; Jonveaux P; Mugneret F; Holder-Espinasse M
    Clin Genet; 2012 Jul; 82(1):41-7. PubMed ID: 21722100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel microdeletion at chromosome 2q31.1-31.2 in a three-generation family presenting duplication of great toes with clinodactyly.
    Tsai LP; Liao HM; Chen YJ; Fang JS; Chen CH
    Clin Genet; 2009 May; 75(5):449-56. PubMed ID: 19459884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An intellectually disabled patient with the 5q14.3q15 microdeletion syndrome associated with an apparently de novo t(2;5)(q13;q14).
    Toral-López J; Buentello-Volante B; Balderas-Minor MM; Amezcua-Herrera C; Valdes-Miranda JM; González-Huerta LM; Gudiño M; Cuevas-Covarrubias SA; Zenteno JC
    Am J Med Genet A; 2012 Apr; 158A(4):942-6. PubMed ID: 22419405
    [No Abstract]   [Full Text] [Related]  

  • 32. Deletion of 4.4 Mb at 2q33.2q33.3 May Cause Growth Deficiency in a Patient with Mental Retardation, Facial Dysmorphic Features and Speech Delay.
    Papoulidis I; Paspaliaris V; Papageorgiou E; Siomou E; Dagklis T; Sotiriou S; Thomaidis L; Manolakos E
    Cytogenet Genome Res; 2015; 145(1):19-24. PubMed ID: 25925190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of single gene deletions at 15q13.3: further evidence that CHRNA7 causes the 15q13.3 microdeletion syndrome phenotype.
    Hoppman-Chaney N; Wain K; Seger PR; Superneau DW; Hodge JC
    Clin Genet; 2013 Apr; 83(4):345-51. PubMed ID: 22775350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Siblings with opposite chromosome constitutions, dup(2q)/del(7q) and del(2q)/dup(7q).
    Shim SH; Shim JS; Min K; Lee HS; Park JE; Park SH; Hwang E; Kim M
    Gene; 2014 Jan; 534(1):100-6. PubMed ID: 24095776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small deletions of SATB2 cause some of the clinical features of the 2q33.1 microdeletion syndrome.
    Rosenfeld JA; Ballif BC; Lucas A; Spence EJ; Powell C; Aylsworth AS; Torchia BA; Shaffer LG
    PLoS One; 2009 Aug; 4(8):e6568. PubMed ID: 19668335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurological manifestations of 2q31 microdeletion syndrome.
    Okamoto N; Kimura S; Shimojima K; Yamamoto T
    Congenit Anom (Kyoto); 2017 Nov; 57(6):197-200. PubMed ID: 28145600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic background of congenital conotruncal heart defects--a study of 45 families.
    Kwiatkowska J; Wierzba J; Aleszewicz-Baranowska J; Ereciński J
    Kardiol Pol; 2007 Jan; 65(1):32-7; discussion 38-9. PubMed ID: 17295158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 1.6-Mb microdeletion in chromosome 17q22 leads to NOG-related symphalangism spectrum disorder without intellectual disability.
    Pang X; Luo H; Chai Y; Wang X; Sun L; He L; Chen P; Wu H; Yang T
    PLoS One; 2015; 10(3):e0120816. PubMed ID: 25815513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A further contribution to the delineation of the 17q21.31 microdeletion syndrome: central nervous involvement in two Italian patients.
    Terrone G; D'Amico A; Imperati F; Carella M; Palumbo O; Gentile M; Canani RB; Melis D; Romano A; Parente I; Riccitelli M; Del Giudice E
    Eur J Med Genet; 2012; 55(8-9):466-71. PubMed ID: 22659270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 15q11.2 microdeletion (BP1-BP2) and developmental delay, behaviour issues, epilepsy and congenital heart disease: a series of 52 patients.
    Vanlerberghe C; Petit F; Malan V; Vincent-Delorme C; Bouquillon S; Boute O; Holder-Espinasse M; Delobel B; Duban B; Vallee L; Cuisset JM; Lemaitre MP; Vantyghem MC; Pigeyre M; Lanco-Dosen S; Plessis G; Gerard M; Decamp M; Mathieu M; Morin G; Jedraszak G; Bilan F; Gilbert-Dussardier B; Fauvert D; Roume J; Cormier-Daire V; Caumes R; Puechberty J; Genevieve D; Sarda P; Pinson L; Blanchet P; Lemeur N; Sheth F; Manouvrier-Hanu S; Andrieux J
    Eur J Med Genet; 2015 Mar; 58(3):140-7. PubMed ID: 25596525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.